Efficacy and safety of Ascoril in the management of cough--National Study Group report.
J Indian Med Assoc
;
2001 Feb; 99(2): 111, 114
Artigo
em Inglês
| IMSEAR
| ID: sea-101642
ABSTRACT
A total of 768 patients were recruited by 81 physicians and paediatricians all over the country in this National Study Group of 'Ascoril + Expectorant'. The results of this first large scale study of a cough formula indicates that 'Ascoril + Expectorant' is effective in controlling cough, breathlessness and decreasing the volume of sputum. No serious adverse events were noted. Ascoril was well accepted by the patients and its efficacy was rated very high by the physician. The National Study Group concludes that 'Ascoril + Expectorant' is highly effective in the management of cough associated with lower respiratory tract infection and COPDs.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Terbutalina
/
Bromoexina
/
Idoso
/
Feminino
/
Humanos
/
Masculino
/
Criança
/
Pré-Escolar
/
Adolescente
/
Resultado do Tratamento
País/Região como assunto:
Ásia
Idioma:
Inglês
Revista:
J Indian Med Assoc
Ano de publicação:
2001
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS